Delayed Japan Exchange Other stock markets | 5-day change | 1st Jan Change | ||
537 JPY | +0.19% | -2.01% | +4.68% |
May. 15 | Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Forecast for the Six Months Ending September 30, 2024 and Full Year Ending March 31, 2025 | CI |
May. 15 | Daiken Medical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2025; Declares Cash Dividend for the Year Ended March 31, 2024, Payable on June 3, 2024 | CI |
May 14, 2024
Share
Daiken Medical Co., Ltd. provided non-consolidated earnings forecast for the six months ending September 30, 2024 and full year ending March 31, 2025. For the six months, the company expects net sales of ¥4,950 million, operating profit of ¥700 million, profit of ¥480 million and earnings per share of ¥16.71.
For the year, the company expects net sales of ¥10,100 million, operating profit of ¥1,500 million, profit of ¥1,030 million and earnings per share of ¥35.85.
Share
© S&P Capital IQ - 2024
Latest news about Daiken Medical Co., Ltd.
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Forecast for the Six Months Ending September 30, 2024 and Full Year Ending March 31, 2025 | CI | |
Daiken Medical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2025; Declares Cash Dividend for the Year Ended March 31, 2024, Payable on June 3, 2024 | CI | |
Daiken Medical Co., Ltd. Provides Dividend Guidance for the Second Quarter Ending September 30, 2024 | CI | |
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Full Year March 31, 2024 | CI | |
Daiken Medical Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 | CI | |
Daiken Medical Co., Ltd. Announces Dividend for the Second Quarter-End of the Fiscal Year Ending March 31, 2024, Payable on December 1, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024 | CI | |
Daiken Medical Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year Ending March 31, 2024 | CI | |
Daiken Medical Co., Ltd. Provides Dividend Guidance for the Second Quarter End and Full Year of 2024 | CI | |
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2023 and Full Year March 31, 2024 | CI | |
Daiken Medical Co., Ltd. Declares Dividend for the Fiscal Year Ending March 31, 2023, Payable on June 5, 2023; Provides Dividend Guidance for Second Quarter and the Year Ending March 31, 2024, Dividend Payments: June 5, 2023 | CI | |
Daiken Medical Co., Ltd. Provides Fiscal Year End Dividend Guidance for the Year Ending March 31, 2023 | CI | |
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023 | CI | |
Daiken Medical Co., Ltd. Announces Dividend for the Second Quarter Ending September 30, 2022, Payable on December 1, 2022; Provides Dividend Guidance for the Year Ending March 31, 2023 | CI | |
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2023 | CI | |
Daiken Medical Co., Ltd. Reports Earnings Results for the Half Year Ended September 30, 2022 | CI | |
Daiken Medical Co., Ltd. Provides Dividend Guidance for the Second Quarter Ending September 30, 2022 and the Full Year Ending March 31, 2023 | CI | |
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2022 and the Full Year Ending March 31, 2023 | CI | |
Daiken Medical Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year 2022; Announces Dividend for the Year Ended March 31, 2022, Payable June 6, 2022 | CI | |
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Six Months Ending September 30, 2022 and Full Year 2022 | CI | |
Daiken Medical Posts Higher Profit, Net Sales in April-December 2021 | MT | |
Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Guidance for the Year Ending March 31, 2022 | CI | |
Daiken Medical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2022 | CI | |
Daiken Medical Co., Ltd. Reports Earnings Results for the Half Year Ended September 30, 2021 | CI | |
Daiken Medical Co., Ltd. Declares Dividend for the Second Quarter Ended September 30, 2021, Payable on December 1, 2021 | CI | |
Daiken Medical Co., Ltd. Provides Dividend Guidance for the Full Year of Fiscal Ending March 31, 2022 | CI |
Chart Daiken Medical Co., Ltd.
More charts
Company Profile
DAIKEN MEDICAL CO., LTD. is a Japan-based company mainly engaged in planning, development, manufacturing and sales of anesthesia and hospital infection control related products. The Companyâs products are divided into five groups. The suction device related products include Fit Fix suction container system and Coopdech QinPot. The syrinjector related products include syrinjector, balloonjector, patient control analgesia (PCA) devices and other pressure infusion instruments. The electric pump related products include syringe pumps and infusion pumps. The medical hand washing machine related products include SteriKeep II and Wipell. The other products include bronchial blocker tube, breath warm and others.
Sector
Calendar
2024-07-30 - Q1 2024 Earnings Release (Projected)
More about the company
Income Statement Evolution
More financial data
Ratings for Daiken Medical Co., Ltd.
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
Sector Medical Equipment
1st Jan change | Capi. | |
---|---|---|
DAIKEN MEDICAL CO., LTD. | +4.68% | 98.64M |
SHOCKWAVE MEDICAL, INC. | +75.69% | 12.57B |
PENUMBRA, INC. | -25.24% | 7.29B |
MASIMO CORPORATION | +9.42% | 6.81B |
+18.48% | 5.67B | |
GETINGE AB | -16.41% | 4.91B |
APT MEDICAL INC. | +17.14% | 4.18B |
ASAHI INTECC CO., LTD. | -21.23% | 3.86B |
INARI MEDICAL, INC. | -22.54% | 2.92B |
NOVOCURE LIMITED | +60.01% | 2.57B |
Medical Equipment
- Stock Market
- Equities
- 7775 Stock
- News Daiken Medical Co., Ltd.
- Daiken Medical Co., Ltd. Provides Non-Consolidated Earnings Forecast for the Six Months Ending September 30, 2024 and Full Year Ending March 31, 2025